CervoMed appoints EVP Clinical Development and EVP Regulatory; COO Cobuzzi to depart July 1, 2025

CervoMed Inc.

Kelly Blackburn promoted to EVP Clinical Development (previously SVP), effective April 16, 2025; base salary $448,360, target bonus 35%.
Mark De Rosch appointed EVP Regulatory and Government Affairs and Program Management, effective May 1, 2025; base salary $465,000, target bonus 35%.
Robert Cobuzzi, COO, to depart July 1, 2025; not standing for re-election; receives lump-sum $479,723 plus pro-rated bonus and COBRA.
Agreements include severance, non-compete, non-solicitation, and change-of-control provisions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.